110 related articles for article (PubMed ID: 24447714)
1. Changes in management and outcome of patients with rectal cancer in Northern Ireland: 1996-2006.
McClements J; Fitzpatrick D; Campbell WJ; Gavin A
Colorectal Dis; 2014 Feb; 16(2):O58-65. PubMed ID: 24447714
[TBL] [Abstract][Full Text] [Related]
2. Improved local control of rectal cancer reduces distant metastases.
Bernstein TE; Endreseth BH; Romundstad P; Wibe A;
Colorectal Dis; 2012 Oct; 14(10):e668-78. PubMed ID: 22646752
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy improves overall survival after TME surgery in mucinous carcinoma of the rectum.
Chand M; Rasheed S; Bhangu A; Stamp GW; Swift RI; Tekkis PP; Brown G
Eur J Surg Oncol; 2014 Feb; 40(2):240-5. PubMed ID: 24286808
[TBL] [Abstract][Full Text] [Related]
4. Improved quality of care for patients undergoing an abdominoperineal excision for rectal cancer.
Bökkerink GM; Buijs EF; de Ruijter W; Rosman C; Sietses C; Strobel R; Heisterkamp J; Nagtegaal ID; Bremers AJ; de Wilt JH
Eur J Surg Oncol; 2015 Feb; 41(2):201-7. PubMed ID: 25572974
[TBL] [Abstract][Full Text] [Related]
5. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.
Park IJ; You YN; Agarwal A; Skibber JM; Rodriguez-Bigas MA; Eng C; Feig BW; Das P; Krishnan S; Crane CH; Hu CY; Chang GJ
J Clin Oncol; 2012 May; 30(15):1770-6. PubMed ID: 22493423
[TBL] [Abstract][Full Text] [Related]
7. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
8. Improving survival and local control in rectal cancer in Catalonia (Spain) in the context of centralisation: A full cycle audit assessment.
Manchon-Walsh P; Aliste L; Espinàs JA; Prades J; Guarga A; Balart J; Biondo S; Castells A; Sanjuan X; Tabernero J; Borras JM;
Eur J Surg Oncol; 2016 Dec; 42(12):1873-1880. PubMed ID: 27624916
[TBL] [Abstract][Full Text] [Related]
9. Quality assurance in rectal cancer treatment.
van de Velde CJ; van den Broek CB
Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
[TBL] [Abstract][Full Text] [Related]
10. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
11. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
[TBL] [Abstract][Full Text] [Related]
12. Survival outcome of operated and non-operated elderly patients with rectal cancer: A Surveillance, Epidemiology, and End Results analysis.
Bhangu A; Kiran RP; Audisio R; Tekkis P
Eur J Surg Oncol; 2014 Nov; 40(11):1510-6. PubMed ID: 24704032
[TBL] [Abstract][Full Text] [Related]
13. Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer.
Pomerri F; Pucciarelli S; Maretto I; Zandonà M; Del Bianco P; Amadio L; Rugge M; Nitti D; Muzzio PC
Surgery; 2011 Jan; 149(1):56-64. PubMed ID: 20452636
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J
J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339
[TBL] [Abstract][Full Text] [Related]
15. The impact of total mesorectal excision in middle and low rectal carcinomas.
Tentes AA; Korakianitis OS; Veliovic D; Sgouridou E; Karagiozoglou C; Moustakas K
J BUON; 2010; 15(1):56-60. PubMed ID: 20414928
[TBL] [Abstract][Full Text] [Related]
16. Clinical factors in prediction of prognosis after anterior resection with total mesorectal excision for carcinoma of the rectum.
Szynglarewicz B; Matkowski R; Forgacz J; Pudelko M; Smorag Z; Dryl J; Kornafel J
Oncol Rep; 2007 Feb; 17(2):471-5. PubMed ID: 17203190
[TBL] [Abstract][Full Text] [Related]
17. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam.
Visser O; Bakx R; Zoetmulder FA; Levering CC; Meijer S; Slors JF; van Lanschot JJ
J Surg Oncol; 2007 May; 95(6):447-54. PubMed ID: 17048237
[TBL] [Abstract][Full Text] [Related]
18. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
[TBL] [Abstract][Full Text] [Related]
19. Complete response after neoadjuvant therapy in rectal cancer: to operate or not to operate?
Dedemadi G; Wexner SD
Dig Dis; 2012; 30 Suppl 2():109-17. PubMed ID: 23207942
[TBL] [Abstract][Full Text] [Related]
20. Results of laparoscopic anterior resection for rectal adenocarcinoma: retrospective analysis of 157 cases.
Pugliese R; Di Lernia S; Sansonna F; Scandroglio I; Maggioni D; Ferrari GC; Costanzi A; Magistro C; De Carli S
Am J Surg; 2008 Feb; 195(2):233-8. PubMed ID: 18083137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
